Metabolic regulation by SIRT3: Implications for tumorigenesis

Trends in Molecular Medicine

Volumn 18, Issue 9, 2012, Pages 516-523

  Finley, Lydia W S ^a   Haigis, Marcia C ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A SYNTHETASE; CYTOCHROME C OXIDASE; GLUTAMATE DEHYDROGENASE; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOCITRATE DEHYDROGENASE 2; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DEACETYLASE; MITOCHONDRIAL ENZYME; ORNITHINE CARBAMOYLTRANSFERASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SIRTUIN 3; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ACETYLATION; BIOMASS PRODUCTION; BIOSYNTHESIS; CANCER CELL; CARCINOGENESIS; CELL PROLIFERATION; CITRIC ACID CYCLE; ELECTRON TRANSPORT; ENERGY YIELD; ENZYME REGULATION; HOMEOSTASIS; HUMAN; MACROMOLECULE; METABOLIC REGULATION; MITOCHONDRION; NONHUMAN; NUTRIENT; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; REVIEW; SIGNAL TRANSDUCTION; TRANSLATION REGULATION;

ACETYLATION; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CITRIC ACID CYCLE; HUMANS; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL; REACTIVE OXYGEN SPECIES; SIRTUIN 3;

EID: 84865576222     PISSN: 14714914     EISSN: 1471499X     Source Type: Journal    
DOI: 10.1016/j.molmed.2012.05.004     Document Type: Review

References (70)

1. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
2. Haigis M.C., Sinclair D.A. Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol. 2010, 5:253-295.
3. Du J., et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 2011, 334:806-809.
4. Peng C., et al. The first identification of lysine malonylation substrates and its regulatory enzyme. Mol. Cell. Proteomics 2011, 10. M111.012658.
5. Smith B.C., Denu J.M. Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases. J. Biol. Chem. 2007, 282:37256-37265.
6. Garrity J., et al. N-lysine propionylation controls the activity of propionyl-CoA synthetase. J. Biol. Chem. 2007, 282:30239-30245.
7. Thao S., Escalante-Semerena J.C. Control of protein function by reversible Nvarepsilon-lysine acetylation in bacteria. Curr. Opin. Microbiol. 2011, 14:200-204.
8. Chen Y., et al. Lysine propionylation and butyrylation are novel post-translational modifications in histones. Mol. Cell. Proteomics 2007, 6:812-819.
9. Guan K.L., Xiong Y. Regulation of intermediary metabolism by protein acetylation. Trends Biochem. Sci. 2011, 36:108-116.
10. Wellen K.E., et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 2009, 324:1076-1080.
11. Zhao S., et al. Regulation of cellular metabolism by protein lysine acetylation. Science 2010, 327:1000-1004.
12. Canto C., et al. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature 2009, 458:1056-1060.
13. Chen D., et al. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev. 2008, 22:1753-1757.
14. Tong L., Denu J.M. Function and metabolism of sirtuin metabolite O-acetyl-ADP-ribose. Biochim. Biophys. Acta 2010, 1804:1617-1625.
15. Kim S.C., et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol. Cell 2006, 23:607-618.
16. Scott I., et al. Identification of a molecular component of the mitochondrial acetyltransferase programme: a novel role for GCN5L1. Biochem. J. 2012, 443:655-661.
17. Bakin R.E., Jung M.O. Cytoplasmic sequestration of HDAC7 from mitochondrial and nuclear compartments upon initiation of apoptosis. J. Biol. Chem. 2004, 279:51218-51225.
18. Verdin E., et al. Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem. Sci. 2010, 35:669-675.
19. Lombard D.B., et al. Mammalian Sir2 homolog SIRT3 regulates global mitochondrial lysine acetylation. Mol. Cell. Biol. 2007, 27:8807-8814.
20. Wallace D.C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 2005, 39:359-407.
21. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
22. Cairns R.A., et al. Regulation of cancer cell metabolism. Nat. Rev. Cancer 2011, 11:85-95.
23. Vander Heiden M.G., et al. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
24. Locasale J.W., Cantley L.C. Metabolic flux and the regulation of mammalian cell growth. Cell Metab. 2011, 14:443-451.
25. Christofk H.R., et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 2008, 452:230-233.
26. Zhang W.C., et al. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 2012, 148:259-272.
27. Locasale J.W., et al. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat. Genet. 2011, 43:869-874.
28. Possemato R., et al. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 2011, 476:346-350.
29. DeBerardinis R.J., et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008, 7:11-20.
30. Srere P.A. The citrate cleavage enzyme. I. Distribution and purification. J. Biol. Chem. 1959, 234:2544-2547.
31. Wise D.R., Thompson C.B. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem. Sci. 2010, 35:427-433.
32. Lin Y.Y., et al. Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPK. Nature 2012, 482:251-255.
33. Schwer B., et al. Calorie restriction alters mitochondrial protein acetylation. Aging Cell 2009, 8:604-606.
34. Hirschey M.D., et al. SIRT3 deficiency and mitochondrial protein hyperacetylation accelerate the development of the metabolic syndrome. Mol. Cell 2011, 44:177-190.
35. Kendrick A.A., et al. Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem J. 2011, 433:505-514.
36. Picklo M.J. Ethanol intoxication increases hepatic N-lysyl protein acetylation. Biochem. Biophys. Res. Commun. 2008, 376:615-619.
37. Yang L., et al. The fasted/fed mouse metabolic acetylome: N6-acetylation differences suggest acetylation coordinates organ-specific fuel switching. J. Proteome Res. 2011, 10:4134-4149.
38. Barger J.L., et al. A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PloS ONE 2008, 3:e2264.
39. Hallows W.C., et al. Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Mol. Cell 2011, 41:139-149.
40. Hirschey M.D., et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010, 464:121-125.
41. Palacios O.M., et al. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging 2009, 1:771-783.
42. Someya S., et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010, 143:802-812.
43. Lanza I.R., et al. Endurance exercise as a countermeasure for aging. Diabetes 2008, 57:2933-2942.
44. Kim H.S., et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010, 17:41-52.
45. Ahn B.H., et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:14447-14452.
46. Cimen H., et al. Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria. Biochemistry 2010, 49:304-311.
47. Bell E.L., et al. SirT3 suppresses hypoxia inducible factor 1alpha and tumor growth by inhibiting mitochondrial ROS production. Oncogene 2011, 30:2986-2996.
48. Finley L.W., et al. Succinate dehydrogenase is a direct target of sirtuin 3 deacetylase activity. PloS ONE 2011, 6:e23295.
49. Jing E., et al. Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin signaling via altered mitochondrial oxidation and reactive oxygen species production. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:14608-14613.
50. Choudhary C., et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science 2009, 325:834-840.
51. Schlicker C., et al. Substrates and regulation mechanisms for the human mitochondrial sirtuins Sirt3 and Sirt5. J. Mol. Biol. 2008, 382:790-801.
52. Wise D.R., et al. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:19611-19616.
53. Mullen A.R., et al. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 2012, 481:385-388.
54. Metallo C.M., et al. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 2012, 481:380-384.
55. Shimazu T., et al. SIRT3 deacetylates mitochondrial 3-hydroxy-3-methylglutaryl CoA synthase 2 and regulates ketone body production. Cell Metab. 2010, 12:654-661.
56. Hallows W.C., et al. Sirtuins deacetylate and activate mammalian acetyl-CoA synthetases. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10230-10235.
57. Schwer B., et al. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10224-10229.
58. Qiu X., et al. Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab. 2010, 12:662-667.
59. Tao R., et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol. Cell 2010, 40:893-904.
60. Liou G.Y., Storz P. Reactive oxygen species in cancer. Free Radic. Res. 2010, 44:479-496.
61. Finley L.W., et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1alpha destabilization. Cancer Cell 2011, 19:416-428.
62. Semenza G.L. Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim. Biophys. Acta 2011, 1813:1263-1268.
63. Kaelin W.G., Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol. Cell 2008, 30:393-402.
64. Majmundar A.J., et al. Hypoxia-inducible factors and the response to hypoxic stress. Mol. Cell 2010, 40:294-309.
65. Gerhart-Hines Z., et al. The cAMP/PKA pathway rapidly activates SIRT1 to promote fatty acid oxidation independently of changes in NAD(+). Mol. Cell 2011, 44:851-863.
66. Cai L., et al. Acetyl-CoA induces cell growth and proliferation by promoting the acetylation of histones at growth genes. Mol. Cell 2011, 42:426-437.
67. Alhazzazi T.Y., et al. Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer. Cancer 2011, 117:1670-1678.
68. Alhazzazi T.Y., et al. SIRT3 and cancer: tumor promoter or suppressor?. Biochim. Biophys. Acta 2011, 1816:80-88.
69. Vander Heiden M.G. Targeting cancer metabolism: a therapeutic window opens. Nat. Rev. Drug Discov. 2011, 10:671-684.
70. Schafer Z.T., et al. Antioxidant and oncogene rescue of metabolic defects caused by loss of matrix attachment. Nature 2009, 461:109-113.